| Block copolymer micelles for the encapsulation and delivery of amphotericin B. | |
| | |
MedLine Citation:
|
PMID: 12033373 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To assess the effect of fatty acid substitution of a micelle-forming poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide) (PEO-b-PHSA) on the encapsulation, hemolytic properties and antifungal activity of amphotericin B (AmB). METHODS: PEO-b-PHSA with three levels of stearic acid substitution were synthesized and used to encapsulate AmB by a solvent evaporation method. Size exclusion chromatography and UV spectroscopy were used to confirm and measure levels of encapsulated AmB. The hemolytic activity of encapsulated AmB toward human red blood cells and its minimum inhibitory concentration against Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans were obtained and compared to AmB alone. RESULTS: An increase in the level of stearic acid substitution on PEO-b-PHSA improved the encapsulation of AmB while reducing its hemolytic activity. PEO-b-PHSA micelles having 50% and 70% stearic acid substitution (mol fatty acid: mol reacted and unreacted hydroxyls) were completely non-hemolytic at 22 microg/ml. At 11% stearic acid substitution, AmB caused 50% hemolysis at 1 microg/ml. AmB in PEO-b-PHSA micelles was as effective as AmB alone against pathogenic fungi. CONCLUSIONS: PEO-b-PHSA micelles with a high level of stearic acid side chain substitution can effectively solubilize AmB, reduce its hemolytic activity yet retain its potent antifungal effects. |
| | |
Authors:
|
Afsaneh Lavasanifar; John Samuel; Saeed Sattari; Glen S Kwon |
Related Documents
:
|
2350263 - Effect of lipids on the lactic acid retardation capacity of tooth enamel and cementum p... 3954813 - A new procedure to immobilize polyriboinosinic-polyribocytidylic acid (poly i:c) on the... 959583 - The levels of main urinary metabolite of prostaglandin f1alpha and f2alpha in human sub... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Pharmaceutical research Volume: 19 ISSN: 0724-8741 ISO Abbreviation: Pharm. Res. Publication Date: 2002 Apr |
Date Detail:
|
Created Date: 2002-05-29 Completed Date: 2002-12-09 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 8406521 Medline TA: Pharm Res Country: United States |
Other Details:
|
Languages: eng Pagination: 418-22 Citation Subset: IM |
Affiliation:
|
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amphotericin B
/
administration & dosage*,
chemistry Drug Compounding / methods Drug Delivery Systems / methods* Hemolysis / drug effects Humans Micelles* Polymers / administration & dosage*, chemistry |
| Grant Support | |
ID/Acronym/Agency:
|
AI43346-01/AI/NIAID NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Micelles; 0/Polymers; 1397-89-3/Amphotericin B |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions.
Next Document: Occlusive properties of monolayer patches: in vitro and in vivo evaluation.